Successful treatment of disseminated human papillomavirus infection with pegylated interferon and ribavirin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20504235.
- Also identified by DOI 10.1086/653428.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a case of disseminated human papillomavirus infection that developed in a patient while receiving efalizumab for the treatment of psoriasis. This infection progressed for several months after efalizumab treatment had been stopped. All human papillomavirus lesions completely resolved after 10 weeks of therapy with a combination of pegylated interferon and ribavirin.
Medical subject headings
- Antiviral Agents
- Interferons
- Papillomavirus Infections
- Ribavirin